A314140 Share Price Performance
₩7,150.00
630.00 (9.66%)
Price ₩7,150.00
Share Price₩7,150.00
Is RP Bio (KOSDAQ:314140) A Risky Investment?
Aug 14
RP Bio Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
A314140 Community Narratives
There are no narratives available yet.
RP Bio Inc. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 350.19
- Gross Margin
- 8.76%
- Net Profit Margin
- 2.35%
- Debt/Equity Ratio
- 15.2%
RP Bio Inc. Competitors
Snowflake Analysis
About A314140
- Founded
- 1983
- Employees
- n/a
- CEO
- WebsiteView website
RP Bio Inc., a bio-health company, engages in the research, development, manufacture, and sale of soft capsules in Korea and internationally. It offers animal, vegetable, and chewable soft capsules; non-synthetic and chewable tablets; hard capsules and jelly sticks; and granule, effervescent granule, and stick type capsule powders. The company was founded in 1983 and is based in Seoul, South Korea.
Market Insight
Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading
South Korean Market Performance
- 7 Days: -0.006%
- 3 Months: 11.7%
- 1 Year: 32.9%
- Year to Date: 44.6%
The market has stayed flat over the 7 days. Meanwhile, the market is actually up 33% over the past year. As for the next few years, earnings are expected to grow by 24% per annum. Market details ›